What are the Rome 4 criteria used for in diagnosing functional gastrointestinal disorders, such as Irritable Bowel Syndrome (IBS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rome IV Criteria for Diagnosing Functional Gastrointestinal Disorders

The Rome IV criteria are the current gold standard for diagnosing functional gastrointestinal disorders (FGIDs), including Irritable Bowel Syndrome (IBS), providing standardized symptom-based diagnostic criteria that help differentiate these disorders from organic diseases with similar presentations.

Evolution of Rome Criteria

The Rome criteria have evolved over time to improve diagnostic accuracy:

  • Manning Criteria (Early precursor): Focused on six symptoms including abdominal pain relieved by defecation, looser/more frequent stools with pain onset, abdominal distension, mucus passage, and sensation of incomplete evacuation 1

  • Rome I (1990s): Required three months of recurrent symptoms including abdominal pain/discomfort relieved with defecation or associated with stool changes, plus two or more supportive symptoms 1

  • Rome II (2000): Simplified to require 12+ weeks in 12 months of abdominal discomfort/pain with two of three features: relief with defecation, change in stool frequency, or change in stool consistency 1

  • Rome III (2006): Similar to Rome II but with refined timeframes and symptom descriptions

  • Rome IV (2016): Current criteria with more restrictive definitions, resulting in significantly lower prevalence estimates (4.1% vs 10.1% with Rome III) 1

Current Rome IV Criteria for IBS

According to the Rome IV criteria, IBS diagnosis requires:

  • Recurrent abdominal pain occurring at least 1 day per week in the last 3 months, associated with 2 or more of the following:

    1. Related to defecation (improvement or worsening)
    2. Associated with a change in stool frequency
    3. Associated with a change in stool form/consistency 2
  • Symptoms must have started at least 6 months before diagnosis 2

IBS Subtypes Under Rome IV

IBS is further classified into subtypes based on predominant stool patterns:

  • IBS with constipation (IBS-C): Hard stools >25% of the time and loose stools <25% of the time
  • IBS with diarrhea (IBS-D): Loose stools >25% of the time and hard stools <25% of the time
  • IBS with mixed bowel habits (IBS-M): Both hard and loose stools >25% of the time
  • IBS unclassified (IBS-U): Insufficient abnormality of stool consistency to meet other subtypes 2

Clinical Application of Rome IV Criteria

Diagnostic Algorithm

  1. Apply Rome IV symptom criteria as outlined above

  2. Screen for alarm features ("red flags"):

    • Age >50 years at symptom onset
    • Short history of symptoms
    • Unintentional weight loss
    • Nocturnal symptoms
    • Family history of colorectal cancer or IBD
    • Anemia
    • Rectal bleeding
    • Recent antibiotic use 2
  3. Perform targeted physical examination:

    • Abdominal examination for masses or organomegaly
    • Rectal examination if indicated
  4. Limited diagnostic testing for patients ≤50 years with typical symptoms and no alarm features:

    • Complete blood count
    • Celiac disease screening
    • C-reactive protein or ESR (especially in younger patients)
    • Stool testing for occult blood 2
  5. Additional investigations if alarm features present or age >45-50:

    • Colonoscopy or flexible sigmoidoscopy with biopsies
    • Thyroid function tests if clinically indicated
    • Stool microscopy in diarrhea-predominant cases 1, 2

Importance and Limitations of Rome IV

Clinical Significance

  • Standardization: Provides consistent diagnostic framework across clinical settings
  • Research utility: Enables comparable patient selection for clinical trials
  • Treatment guidance: Helps direct therapy based on predominant symptoms
  • Reduced unnecessary testing: Allows confident diagnosis with minimal investigations in typical cases

Key Limitations

  • More restrictive than Rome III: Up to 50% of patients previously diagnosed with IBS under Rome III no longer meet criteria under Rome IV 1
  • Symptom fluctuation: Patients may shift between subtypes over time
  • Overlap with other FGIDs: Symptoms may overlap with functional diarrhea, functional constipation, or functional bloating 1
  • Psychological factors: Rome IV acknowledges but doesn't fully incorporate the biopsychosocial model into diagnostic criteria 3

Clinical Pearls

  • A positive diagnosis using Rome IV criteria is preferred over a diagnosis of exclusion
  • The absence of abdominal pain makes IBS diagnosis untenable 4
  • Working diagnosis can be safely made in general practice with typical symptoms, normal physical examination, and absence of alarm features 1
  • Patients with atypical symptoms, short symptom history, or age >45 at symptom onset should be referred for further evaluation 2
  • The Rome criteria were initially developed for research but have been refined to be clinically useful and relevant 4

By using the Rome IV criteria systematically, clinicians can make accurate diagnoses of IBS and other functional gastrointestinal disorders, leading to appropriate management strategies and improved patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing and Managing IBS Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Rome IV: Irritable bowel syndrome - A functional disorder.

Best practice & research. Clinical gastroenterology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.